These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 36384532)

  • 41. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Plausibility of a third wave of COVID-19 in India: A mathematical modelling based analysis.
    Mandal S; Arinaminpathy N; Bhargava B; Panda S
    Indian J Med Res; 2021 May&Jun; 153(5&6):522-532. PubMed ID: 34643562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Kinetics of vaccine-induced neutralizing antibody titers and estimated protective immunity against wild-type SARS-CoV-2 and the Delta variant: A prospective nationwide cohort study comparing three COVID-19 vaccination protocols in South Korea.
    Nham E; Ko JH; Song KH; Choi JY; Kim ES; Kim HJ; Kim B; Lim HY; Kim KC; Jang HC; Lee KH; Song YG; Baek YJ; Ahn JY; Choi JY; Kim YC; Park YS; Choi WS; Bae S; Kim SH; Kang ES; Jeong HW; Kim SW; Kwon KT; Kim SS; Peck KR
    Front Immunol; 2022; 13():968105. PubMed ID: 36211416
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility to Resurgent COVID-19 Outbreaks Following Vaccine Rollouts: A Modeling Study.
    Neofotistos G; Angeli M; Mattheakis M; Kaxiras E
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298791
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of immune evasion, waning and boosting on dynamics of population mixing between a vaccinated majority and unvaccinated minority.
    Fisman DN; Amoako A; Simmons A; Tuite AR
    PLoS One; 2024; 19(4):e0297093. PubMed ID: 38574059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
    Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
    Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacton Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021-Oct 2022).
    Chrysostomou AC; Vrancken B; Haralambous C; Alexandrou M; Gregoriou I; Ioannides M; Ioannou C; Kalakouta O; Karagiannis C; Marcou M; Masia C; Mendris M; Papastergiou P; Patsalis PC; Pieridou D; Shammas C; Stylianou DC; Zinieri B; Lemey P; The Comessar Network ; Kostrikis LG
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766339
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study.
    Moore S; Hill EM; Tildesley MJ; Dyson L; Keeling MJ
    Lancet Infect Dis; 2021 Jun; 21(6):793-802. PubMed ID: 33743847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multi-Faceted Analysis of COVID-19 Epidemic in Korea Considering Omicron Variant: Mathematical Modeling-Based Study.
    Ko Y; Mendoza VM; Mendoza R; Seo Y; Lee J; Lee J; Kwon D; Jung E
    J Korean Med Sci; 2022 Jul; 37(26):e209. PubMed ID: 35790210
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modelling of hypothetical SARS-CoV-2 point of care tests for routine testing in residential care homes: rapid cost-effectiveness analysis.
    Stevenson M; Metry A; Messenger M
    Health Technol Assess; 2021 Jun; 25(39):1-74. PubMed ID: 34142943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the transition of COVID-19 burden towards the young population while vaccines are rolled out in China.
    Cai J; Yang J; Deng X; Peng C; Chen X; Wu Q; Liu H; Zhang J; Zheng W; Zou J; Zhao Z; Ajelli M; Yu H
    Emerg Microbes Infect; 2022 Dec; 11(1):1205-1214. PubMed ID: 35380100
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A versatile web app for identifying the drivers of COVID-19 epidemics.
    Getz WM; Salter R; Luisa Vissat L; Horvitz N
    J Transl Med; 2021 Mar; 19(1):109. PubMed ID: 33726787
    [TBL] [Abstract][Full Text] [Related]  

  • 54. SARS-CoV-2 elicits non-sterilizing immunity and evades vaccine-induced immunity: implications for future vaccination strategies.
    Beukenhorst AL; Koch CM; Hadjichrysanthou C; Alter G; de Wolf F; Anderson RM; Goudsmit J
    Eur J Epidemiol; 2023 Mar; 38(3):237-242. PubMed ID: 36738380
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Herd immunity: challenges and the way forward in Korea.
    Oh J; Kim S; Ryu B; Shin M; Kim BI
    Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants.
    Jing S; Milne R; Wang H; Xue L
    J Theor Biol; 2023 Aug; 570():111522. PubMed ID: 37210068
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Projected resurgence of COVID-19 in the United States in July-December 2021 resulting from the increased transmissibility of the Delta variant and faltering vaccination.
    Truelove S; Smith CP; Qin M; Mullany LC; Borchering RK; Lessler J; Shea K; Howerton E; Contamin L; Levander J; Kerr J; Hochheiser H; Kinsey M; Tallaksen K; Wilson S; Shin L; Rainwater-Lovett K; Lemairtre JC; Dent J; Kaminsky J; Lee EC; Perez-Saez J; Hill A; Karlen D; Chinazzi M; Davis JT; Mu K; Xiong X; Pastore Y Piontti A; Vespignani A; Srivastava A; Porebski P; Venkatramanan S; Adiga A; Lewis B; Klahn B; Outten J; Orr M; Harrison G; Hurt B; Chen J; Vullikanti A; Marathe M; Hoops S; Bhattacharya P; Machi D; Chen S; Paul R; Janies D; Thill JC; Galanti M; Yamana TK; Pei S; Shaman JL; Healy JM; Slayton RB; Biggerstaff M; Johansson MA; Runge MC; Viboud C
    Elife; 2022 Jun; 11():. PubMed ID: 35726851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mathematical models for devising the optimal SARS-CoV-2 strategy for eradication in China, South Korea, and Italy.
    Jiang S; Li Q; Li C; Liu S; He X; Wang T; Li H; Corpe C; Zhang X; Xu J; Wang J
    J Transl Med; 2020 Sep; 18(1):345. PubMed ID: 32891155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substantial impact of post-vaccination contacts on cumulative infections during viral epidemics.
    Rochman N; Wolf Y; V Koonin E
    F1000Res; 2021; 10():315. PubMed ID: 34504684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.